174 related articles for article (PubMed ID: 9030563)
1. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties.
Lochter A; Srebrow A; Sympson CJ; Terracio N; Werb Z; Bissell MJ
J Biol Chem; 1997 Feb; 272(8):5007-15. PubMed ID: 9030563
[TBL] [Abstract][Full Text] [Related]
2. Expression of stromelysin-1 and TIMP-1 in the involuting mammary gland and in early invasive tumors of the mouse.
Li F; Strange R; Friis RR; Djonov V; Altermatt HJ; Saurer S; Niemann H; Andres AC
Int J Cancer; 1994 Nov; 59(4):560-8. PubMed ID: 7960227
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of stromelysin-1 gene expression is altered during progression of mouse mammary epithelial cells from functionally normal to malignant.
Lochter A; Werb Z; Bissell MJ
Matrix Biol; 1999 Oct; 18(5):455-67. PubMed ID: 10601733
[TBL] [Abstract][Full Text] [Related]
4. Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis.
Witty JP; Lempka T; Coffey RJ; Matrisian LM
Cancer Res; 1995 Apr; 55(7):1401-6. PubMed ID: 7882342
[TBL] [Abstract][Full Text] [Related]
5. alpha1 and alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression.
Lochter A; Navre M; Werb Z; Bissell MJ
Mol Biol Cell; 1999 Feb; 10(2):271-82. PubMed ID: 9950676
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development.
Witty JP; Wright JH; Matrisian LM
Mol Biol Cell; 1995 Oct; 6(10):1287-303. PubMed ID: 8573787
[TBL] [Abstract][Full Text] [Related]
7. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression.
Sympson CJ; Talhouk RS; Alexander CM; Chin JR; Clift SM; Bissell MJ; Werb Z
J Cell Biol; 1994 May; 125(3):681-93. PubMed ID: 8175886
[TBL] [Abstract][Full Text] [Related]
8. Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development.
Thomasset N; Lochter A; Sympson CJ; Lund LR; Williams DR; Behrendtsen O; Werb Z; Bissell MJ
Am J Pathol; 1998 Aug; 153(2):457-67. PubMed ID: 9708806
[TBL] [Abstract][Full Text] [Related]
9. Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1.
Sympson CJ; Bissell MJ; Werb Z
Semin Cancer Biol; 1995 Jun; 6(3):159-63. PubMed ID: 7495984
[TBL] [Abstract][Full Text] [Related]
10. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.
Sternlicht MD; Lochter A; Sympson CJ; Huey B; Rougier JP; Gray JW; Pinkel D; Bissell MJ; Werb Z
Cell; 1999 Jul; 98(2):137-46. PubMed ID: 10428026
[TBL] [Abstract][Full Text] [Related]
11. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.
Sternlicht MD; Bissell MJ; Werb Z
Oncogene; 2000 Feb; 19(8):1102-13. PubMed ID: 10713697
[TBL] [Abstract][Full Text] [Related]
12. Epithelial cells up-regulate matrix metalloproteinases in cells within the same mammary carcinoma that have undergone an epithelial-mesenchymal transition.
Martorana AM; Zheng G; Crowe TC; O'Grady RL; Lyons JG
Cancer Res; 1998 Nov; 58(21):4970-9. PubMed ID: 9810007
[TBL] [Abstract][Full Text] [Related]
13. Effects of extracellular matrix on the growth and casein gene expression of primary mouse mammary tumor cells in vitro.
Chou JL; Shen ZX; Stolfi RL; Martin DS; Waxman S
Cancer Res; 1989 Oct; 49(19):5371-6. PubMed ID: 2766303
[TBL] [Abstract][Full Text] [Related]
14. Metastatic ability of MXT mouse mammary subpopulations correlates with clonal expression and/or membrane-association of gelatinase A.
Llorens A; Vinyals A; Alia P; López-Barcons L; Gonzalez-Garrigues M; Fabra A
Mol Carcinog; 1997 May; 19(1):54-66. PubMed ID: 9180929
[TBL] [Abstract][Full Text] [Related]
15. Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Bolon I; Devouassoux M; Robert C; Moro D; Brambilla C; Brambilla E
Am J Pathol; 1997 May; 150(5):1619-29. PubMed ID: 9137088
[TBL] [Abstract][Full Text] [Related]
16. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution.
Talhouk RS; Bissell MJ; Werb Z
J Cell Biol; 1992 Sep; 118(5):1271-82. PubMed ID: 1512297
[TBL] [Abstract][Full Text] [Related]
17. The role of stromelysin-1 in stromal-epithelial interactions and cancer.
Wiesen JF; Werb Z
Enzyme Protein; 1996; 49(1-3):174-81. PubMed ID: 8797005
[TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of the ets transcription factor ER81 in transgenic mouse mammary gland enhances both urokinase plasminogen activator and stromelysin-1 transcription.
Netzer S; Leenders F; Dumont P; Baert JL; de Launoit Y
Transgenic Res; 2002 Apr; 11(2):123-31. PubMed ID: 12054346
[TBL] [Abstract][Full Text] [Related]
19. Matrix-degrading metalloproteinases in tumor progression.
Matrisian LM; Wright J; Newell K; Witty JP
Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
[TBL] [Abstract][Full Text] [Related]
20. Stromelysin-1 activation correlates with invasiveness in squamous cell carcinoma.
De Angelis T; Noè A; Chatterjee M; Mulholland J
J Invest Dermatol; 2002 May; 118(5):759-66. PubMed ID: 11982752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
